Skip to Content

In studies, by how long does Lonsurf increase survival?

Answers (1)

Official Answer by Drugs.com 9 Mar 2016

Lonsurf (generic names: trifluridine and tipiracil) is approved for patients with advanced (metastatic) colorectal cancer who are no longer responding to other therapies, such as chemotherapy and biological therapy.

Lonsurf is a nucleoside metabolic inhibitor which is incorporated directly into DNA and interferes with its function. The blood level of trifluridine is maintained by the enzyme inhibitor tipiracil.

In clinical studies, patients treated with Lonsurf lived an average of 7.1 months compared to 5.3 months for those treated with placebo (a sugar pill). On average, the time to cancer progression was two months for patients on Lonsurf compared to 1.7 months for patients receiving placebo.

Common side effects with Lonsurf include anemia, neutropenia (low white blood cells), thrombocytopenia (low blood platelets), physical weakness, extreme tiredness and lack of energy (fatigue).

Votes: +0
Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

How does Yosprala work?

Posted 30 Nov 2016 1 answerFAQ by Drugs.com

How is Cuvitru administered?

Posted 30 Nov 2016 1 answerFAQ by Drugs.com

What is the difference between Erelzi and Enbrel?

Posted 30 Nov 2016 1 answerFAQ by Drugs.com

How is Troxyca ER formulated to be abuse deterrent?

Posted 30 Nov 2016 1 answerFAQ by Drugs.com

How long does the flu last for?

Posted 16 Dec 2016 1 answerFAQ by Drugs.com